In Brief: Adeza female infertility test
This article was originally published in The Gray Sheet
Executive Summary
Adeza female infertility test: Adeza Biomedical plans worldwide launch of E-tegrity test for female infertility on Jan. 1. The assay detects the B-3 integrin protein in uterine fundus tissue. "It appears that some women with unexplained infertility may have biochemical alterations affecting uterine function that can now be detected using the E-tegrity test," the company says. Adeza performs the test at its clinical laboratory, with results available in "less than 14 days"...